- Home
- BTBT vs RVNC Comparison
BTBT vs RVNC Comparison
Compare BTBT & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTBT
- RVNC
- Stock Information
- Founded
- BTBT 2015
- RVNC 1999
- Country
- BTBT United States
- RVNC United States
- Employees
- BTBT N/A
- RVNC N/A
- Industry
- BTBT Finance: Consumer Services
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- BTBT Finance
- RVNC Health Care
- Exchange
- BTBT Nasdaq
- RVNC Nasdaq
- Market Cap
- BTBT 467.0M
- RVNC 546.4M
- IPO Year
- BTBT 2018
- RVNC 2014
- Fundamental
- Price
- BTBT $4.13
- RVNC $5.28
- Analyst Decision
- BTBT Strong Buy
- RVNC Buy
- Analyst Count
- BTBT 2
- RVNC 10
- Target Price
- BTBT $6.50
- RVNC $10.86
- AVG Volume (30 Days)
- BTBT 8.3M
- RVNC 1.8M
- Earning Date
- BTBT 11-12-2024
- RVNC 11-06-2024
- Dividend Yield
- BTBT N/A
- RVNC N/A
- EPS Growth
- BTBT N/A
- RVNC N/A
- EPS
- BTBT 0.27
- RVNC N/A
- Revenue
- BTBT $86,851,522.00
- RVNC $251,178,000.00
- Revenue This Year
- BTBT $192.83
- RVNC $20.36
- Revenue Next Year
- BTBT $40.81
- RVNC $31.66
- P/E Ratio
- BTBT $15.34
- RVNC N/A
- Revenue Growth
- BTBT 153.87
- RVNC 40.23
- 52 Week Low
- BTBT $1.76
- RVNC $2.30
- 52 Week High
- BTBT $5.27
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- BTBT 69.21
- RVNC 43.99
- Support Level
- BTBT $2.91
- RVNC $5.10
- Resistance Level
- BTBT $3.52
- RVNC $5.43
- Average True Range (ATR)
- BTBT 0.24
- RVNC 0.17
- MACD
- BTBT 0.09
- RVNC 0.02
- Stochastic Oscillator
- BTBT 99.19
- RVNC 64.29
About BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries.. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. It generates revenue from digital asset mining and ETH staking business.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.